The Week Ahead - Daily Telegraph UK - 12 hours ago
... to fight off challenges not only to Augmentin but also to its antidepressant Paxil.
Investors will want to hear how chief executive Jean-Pierre Garnier plans ...

Pharmaceuticals not always the best financial medicine - The Scotsman - 12 Jul 2002
... month, it expects to wage a legal war over its patent for anti-depressant Paxil,
another of its mega-sellers. Another uncertainty for Glaxo is the speculation ...

Panic sales drive FTSE below 4,000 - The Scotsman - 15 Jul 2002
... 50p, or 4.1 per cent, to 1,175p amid worries about its anti-depressant Paxil, which
is currently under patent challenge. The possible tie-up between Pfizer and ...

Oil and drugs pull down Footsie - Ananova - 15 Jul 2002
... with GlaxoSmithKline off 35p at £11.90 amid worries about its antidepressant Paxil,
which is currently under patent challenge. Rival AstraZeneca has fallen ...

Hormone therapy: not a simple case of yes or no - International Herald Tribune - 17 Jul 2002
... about 70 percent of women, Norton said, as do anti-depressants like Effexor, Paxil
and Prozac. Women using anti-depressants to treat hot flashes typically take ...

Also:

Menopausal hormone therapy: Not a simple case of yes or no - International Herald Tribune

NTSB says pilot of sightseeing plane took unauthorized drug - Nando Times - 18 Jul 2002
... NTSB said in a report released Monday. The drug, which is marketed as Paxil, is
not approved by the Federal Aviation Administration. Beer and his doctor did ...

Glaxo not seeking merger partner, president says - CBS - 18 Jul 2002
... of many new drugs, she said. Glaxo is the maker of the antidepressant Paxil and
nicotine replacement Nicoderm. The company is also the largest maker of AIDS ...

Anti-anxiety drug ruled a factor in Alaska air crash - Seattle Post Intelligencer - 18 Jul 2002
... released Monday. Beer was prescribed the drug, which is marketed under the name Paxil,
to combat anxiety over flying in bad weather and giving presentations to ...

Footsie closes at lowest point since December 1996 - Ananova - 15 Jul 2002
... weighed on the market, down 50p at £11.75 amid worries about its antidepressant
Paxil, which is currently under patent challenge. Markets around the world are ...

Oil stocks drag Footsie down - Ananova - 15 Jul 2002
... on the market, down 16p at £12.09 amid worries about its antidepressant Paxil, which
is currently under patent challenge. Rival AstraZeneca, however, regained ...